GENOMECARE CO LTD

http://genomecare.tradekorea.com

We, Genomecare co,Ltd.,are looking for Overseas Sales Partnership as a distributor or an Exclusive Partner(Technology Transfer).Genomcare is serving NIPT (Non-invasive prenatal Test) &PGS (Pre-implantation genetic Screening) base on NGS(Next generation Sequencing) service to our customer utilizing proton and S5XL (ThermoFisher) which are screening Chromosomal abnormalities of Fetus and maternal and performed on Embryo during IVF treatment to screen for numerical chromosomal abnormalities.We published the clinical results of NIPT in PLOS ONE&BMC Medical Genomics (Oct 2014, April 2016, Oct 2016) worldwide authoritative scientific journal. Through these experiments, Genomecare became the first sacrificially verified NIPT service provider in Korea with world-class level of NGS and data Analysis competency.ION PROTONThe Ion Proton system makes affordable, high-quality next-generation sequencing to elucidate vriants important for the heritability of cancer as well as Mendelian and complex disorders. Exome sequecning is a targeted sequencing approach that is restricted the protein-coding region of genomes. The exome is estimated to encompass approximately 1% of the genome, yet contains approximately 85% of disease-causing mutations. For genetic researchers trying to unravel the disease-causing genes of over 6,800 rare disease, exome sequencing enables the identification of common single-nucleotide variants(SNVs) and small insertions or deletions (indels), as well as rare de novo mutations that may explain the heritabiltiy of Mendelian and complex disorders.